Head-To-Head Contrast: Atyr PHARMA (ATYR) vs. The Competition
Atyr PHARMA (NASDAQ:ATYR – Get Free Report) is one of 292 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare Atyr PHARMA to similar businesses based on the strength of its institutional ownership, analyst recommendations, dividends, earnings, valuation, risk and profitability. Insider […]
More Stories
Algoma Steel Group Inc. (NASDAQ:ASTLW) Short Interest Update
Algoma Steel Group Inc. (NASDAQ:ASTLW – Get Free Report) was the target of a significant decline in short interest in...
Women and girls in Sudan disproportionately impacted by ongoing conflict
Women and girls in the midst of the brutal conflict between rival militaries in Sudan are being disproportionately impacted, including...
South32 Limited (OTCMKTS:SOUHY) Short Interest Up 518.1% in September
South32 Limited (OTCMKTS:SOUHY – Get Free Report) was the target of a large growth in short interest in the month...
Shiseido Company, Limited (OTCMKTS:SSDOY) Short Interest Up 204.8% in September
Shiseido Company, Limited (OTCMKTS:SSDOY – Get Free Report) was the recipient of a large increase in short interest during the...
X-Links Crude Oil Shares Covered Call ETN (NASDAQ:USOI) Short Interest Update
X-Links Crude Oil Shares Covered Call ETN (NASDAQ:USOI – Get Free Report) was the recipient of a large growth in...
Insider Selling: Sezzle Inc. (NASDAQ:SEZL) Director Sells $297,630.00 in Stock
Sezzle Inc. (NASDAQ:SEZL – Get Free Report) Director Paul Martin Purcell sold 1,800 shares of the stock in a transaction...